These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2219689)

  • 41. The use of proton relaxation enhancers in magnetic resonance imaging.
    Carr DH
    Magn Reson Imaging; 1985; 3(1):17-25. PubMed ID: 3923290
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies.
    Carr DH
    Physiol Chem Phys Med NMR; 1984; 16(2):137-44. PubMed ID: 6438657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Magnetic resonance imaging in digestive and abdominal pathology].
    Legmann P
    Gastroenterol Clin Biol; 1990; 14(2 ( Pt 3)):T8-12. PubMed ID: 2182368
    [No Abstract]   [Full Text] [Related]  

  • 44. MR of the liver: from breakthrough to clinical application.
    Bartolozzi C
    Abdom Imaging; 2012 Apr; 37(2):154. PubMed ID: 21710173
    [No Abstract]   [Full Text] [Related]  

  • 45. Magnetic resonance imaging of focal and diffuse hepatic disease.
    Siegelman ES; Outwater EK
    Semin Ultrasound CT MR; 1998 Feb; 19(1):2-34. PubMed ID: 9503518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MR imaging of focal hepatic injury due to use of surgical retractors.
    Earls JP; Krinsky GA; DeCorato DR
    AJR Am J Roentgenol; 1996 Sep; 167(3):816-7. PubMed ID: 8751708
    [No Abstract]   [Full Text] [Related]  

  • 47. MR imaging of the pediatric liver.
    Carneiro RC; Fordham LA; Semelka RC
    Magn Reson Imaging Clin N Am; 2002 Feb; 10(1):137-64. PubMed ID: 11998571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast agents for MR imaging of the liver: a clinical overview.
    Mahfouz AE; Hamm B; Taupitz M
    Eur Radiol; 1997; 7(4):507-13. PubMed ID: 9204329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dynamic MR tomography of intrahepatic tumors].
    Hamm B; Felix R; Wolf KJ
    Rofo; 1989 Apr; 150(4):434-41. PubMed ID: 2539622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ; Peters PE
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver I: Currently available gadolinium chelates.
    Mitchell DG
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):37-51. PubMed ID: 8673715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Magnetic resonance tomography in focal diseases of the liver (review)].
    Kholin AV
    Vestn Rentgenol Radiol; 1990; (2):59-63. PubMed ID: 2219689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.